The apoptotic efficacy of succinic acid on renal cancer cell lines

Goksu Kasarci1, Baris Ertugrul1, Elif Sinem Iplik2

  • 1Department of Molecular Medicine, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Capa, Istanbul, Turkey.

Insights

Succinic acid demonstrates significant anticancer effects on renal cancer cell lines by inducing apoptosis. This non-toxic substance shows promise as a potential therapeutic agent for kidney cancer treatment.

Area of Science:

  • Oncology
  • Biochemistry

Background:

  • Non-toxic substances are increasingly explored for cancer prophylaxis.
  • Succinic acid and its derivatives have shown potential anticancer activity by inducing apoptosis.

Purpose of the Study:

  • To investigate the anticancer activity of succinic acid on renal cancer cell lines for the first time.
  • To evaluate the cytotoxic and apoptotic effects of succinic acid on CAKI-2 and ACHN renal cancer cells and MRC-5 healthy cells.

Main Methods:

  • WST-1 cytotoxicity assay to determine cell viability.
  • Annexin V test and cell death ELISA kit to measure apoptotic activity.
  • Utilized CAKI-2, ACHN (renal cancer), and MRC-5 (healthy) cell lines.

Main Results:

  • Succinic acid (25 µM and 50 µM) significantly reduced viability in CAKI-2 and ACHN cells but not in MRC-5 cells.
  • Succinic acid induced apoptosis in both CAKI-2 and ACHN cells, confirmed by Annexin V and ELISA.
  • ELISA showed a substantial increase in apoptotic fragment rates in treated cancer cells.

Conclusions:

  • Succinic acid exhibits potent cytotoxic and apoptotic effects specifically on renal cancer cells.
  • Succinic acid is a potential therapeutic agent for renal cancer, warranting further molecular investigation.
  • The metabolic activity of succinic acid makes it an attractive candidate for cancer treatment approaches.